155 related articles for article (PubMed ID: 24777624)
1. Graves' orbitopathy precipitated by iatrogenic hypothyroidism secondary to carbimazole for Graves' disease.
Dutta D; Kumar M; Mukhopadhyay S; Chowdhury S
Indian J Pediatr; 2014 Nov; 81(11):1244-5. PubMed ID: 24777624
[No Abstract] [Full Text] [Related]
2. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
3. Carbimazole-induced myositis in the treatment of Graves' disease: a complication in genetically susceptible individuals?
Lim AY; Kek PC; Soh AW
Singapore Med J; 2013 Jul; 54(7):e133-6. PubMed ID: 23900475
[TBL] [Abstract][Full Text] [Related]
4. Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.
Žarković M; Wiersinga W; Perros P; Bartalena L; Donati S; Okosieme O; Morris D; Fichter N; Lareida J; Daumerie C; Burlacu MC; Kahaly GJ; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
J Endocrinol Invest; 2021 Feb; 44(2):371-378. PubMed ID: 32524368
[TBL] [Abstract][Full Text] [Related]
5. [Hypersensitivity syndrome : a rare but severe adverse effect of antithyroid drugs].
Vinzio S; Goichot B; Andrès E; Schlienger JL
Ann Endocrinol (Paris); 2000 May; 61(2):151-3. PubMed ID: 10891666
[TBL] [Abstract][Full Text] [Related]
6. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.
Bowman P; Osborne NJ; Sturley R; Vaidya B
QJM; 2012 Feb; 105(2):189-93. PubMed ID: 21258054
[TBL] [Abstract][Full Text] [Related]
7. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
8. [An underestimate iatrogenic effect of antithyroid drugs: Acute pancreatitis].
Ben Hamou A; Banu I; Dupuy O
Presse Med; 2019 Nov; 48(11 Pt 1):1334-1336. PubMed ID: 31727489
[No Abstract] [Full Text] [Related]
9. Acute pancreatitis, hepatic cholestasis, and erythema nodosum induced by carbimazole treatment for Graves' disease.
Marazuela M; Sánchez de Paco G; Jiménez I; Carraro R; Fernández-Herrera J; Pajares JM; Gómez-Pan A
Endocr J; 2002 Jun; 49(3):315-8. PubMed ID: 12201214
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
Chen DY; Chen TH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
[TBL] [Abstract][Full Text] [Related]
11. [Polyarthritis and synthetic antithyroid agents].
Ansart S; Le Gal G; Pennec YL
Rev Med Interne; 2000 Aug; 21(8):710. PubMed ID: 10989501
[No Abstract] [Full Text] [Related]
12. Association between radioiodine therapy for Graves' hyperthyroidism and thyroid-associated ophthalmopathy.
El-Kaissi S; Bowden J; Henry MJ; Yeo M; Champion BL; Brotchie P; Nicholson GC; Wall JR
Int Ophthalmol; 2010 Aug; 30(4):397-405. PubMed ID: 20405165
[TBL] [Abstract][Full Text] [Related]
13. Carbimazole-induced pancytopaenia.
Psomadakis C; Creamer A; Baynes C
Br J Hosp Med (Lond); 2016 Apr; 77(4):248-9. PubMed ID: 27071434
[No Abstract] [Full Text] [Related]
14. Carbimazole embryopathy.
El Guendouz F; Hammoune N; Hommadi A; Zerhouni H; Baizri H
Ann Endocrinol (Paris); 2017 Oct; 78(5):478-480. PubMed ID: 28870708
[No Abstract] [Full Text] [Related]
15. Carbimazole induced ANCA positive vasculitis.
Pandey S; Kushwaha RS; Mehndiratta P; Mehndiratta MM
J Assoc Physicians India; 2008 Oct; 56():801-3. PubMed ID: 19263707
[TBL] [Abstract][Full Text] [Related]
16. Carbimazole induced eosinophilic granulomatous vasculitis localized to the stomach.
Sève P; Stankovic K; Michalet V; Vial T; Scoazec JY; Broussolle C
J Intern Med; 2005 Aug; 258(2):191-5. PubMed ID: 16018796
[TBL] [Abstract][Full Text] [Related]
17. Fatality complicating agranulocytosis in the setting of carbimazole therapy.
Lynch MJ; Woodford NW
Forensic Sci Med Pathol; 2008; 4(4):246-9. PubMed ID: 19291446
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves' disease.
Miller RM; Savige J; Nassis L; Cominos BI
Australas J Dermatol; 1998 May; 39(2):96-9. PubMed ID: 9611379
[TBL] [Abstract][Full Text] [Related]
19. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
[TBL] [Abstract][Full Text] [Related]
20. Successful radioiodine treatment in a 3 year old child with Graves' disease following antithyroid medication induced neutropenia.
Rahman MA; Birrell G; Stewart H; Lucraft H; Cheetham TD
Arch Dis Child; 2003 Feb; 88(2):158-9. PubMed ID: 12538324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
